HIV coinfection with hepatitis b epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{HIV coinfection with hepatitis b}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about e...") |
No edit summary |
||
| Line 15: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Revision as of 15:48, 7 December 2012
|
HIV coinfection with hepatitis b Microchapters |
|
Differentiating HIV coinfection with hepatitis b from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV coinfection with hepatitis b epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of HIV coinfection with hepatitis b epidemiology and demographics |
|
FDA on HIV coinfection with hepatitis b epidemiology and demographics |
|
CDC on HIV coinfection with hepatitis b epidemiology and demographics |
|
HIV coinfection with hepatitis b epidemiology and demographics in the news |
|
Blogs on HIV coinfection with hepatitis b epidemiology and demographics |
|
Directions to Hospitals Treating HIV coinfection with hepatitis b |
|
Risk calculators and risk factors for HIV coinfection with hepatitis b epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Epidemiology
In areas of low endemicity, such as North America, Australia and Europe, HBV and HIV infection are usually acquired in adulthood through sexual or percutaneous transmission. In areas of low endemicity, the prevalence of chronic coinfection is around 5-7% among HIV-infected individuals.[1] In countries with intermediate and high HBV endemicity, the main routes of transmission of HBV are perinatal or in early childhood; in these countries HBV coinfection rates are 10-20%.[2][3][4]
References
- ↑ Alter MJ (2006). "Epidemiology of viral hepatitis and HIV coinfection". J. Hepatol. 44 (1 Suppl): S6–9. doi:10.1016/j.jhep.2005.11.004. PMID 16352363. Retrieved 2012-03-29.
- ↑ Lee HC, Ko NY, Lee NY, Chang CM, Ko WC (2008). "Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users". J. Formos. Med. Assoc. 107 (5): 404–11. doi:10.1016/S0929-6646(08)60106-0. PMID 18492625. Retrieved 2012-03-29. Unknown parameter
|month=ignored (help) - ↑ Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Hart IJ, Munthali C, Beeching NJ, Zijlstra EE (2008). "Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi". J. Infect. 57 (1): 72–7. doi:10.1016/j.jinf.2008.05.004. PMID 18555534. Retrieved 2012-03-29. Unknown parameter
|month=ignored (help) - ↑ Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S (2008). "Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study)". J. Med. Virol. 80 (8): 1332–6. doi:10.1002/jmv.21236. PMID 18551596. Retrieved 2012-03-29. Unknown parameter
|month=ignored (help)